Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 61, 2001, Pages 263-272

  Kim, S H ^a   Nairn, A C ^b   Cairns, N ^c   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ROCKEFELLER UNIVERSITY   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASES; CYCLIC AMP REGULATED PHOSPHOPROTEIN 19; CYCLIC AMP-REGULATED PHOSPHOPROTEIN 19; MESSENGER RNA; PHOSPHOPROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBELLUM CORTEX; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DOWN REGULATION; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TEMPORAL CORTEX; TISSUE DISTRIBUTION; BRAIN; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHOSPHORYLATION;

ALZHEIMER DISEASE; BASE SEQUENCE; BRAIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN SYNDROME; GENE EXPRESSION PROFILING; HUMAN; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0035233457     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6262-0_21     Document Type: Article

References (25)

1. Brene S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H (1994) Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J Neurosci 14: 985-998
2. Browning MD, Huganir R, Greengard P (1985) Protein phosphorylation and neuronal function. J Neurochem 45: 11-23
3. Dierssen M, Vallina IF, Baamonde C, Lumbreras MA, Martinez-Cue C, Calatayud SG, Florez J (1996) Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model. Brain Res Dev Brain Res 95: 122-124
4. Dierssen M, Vallina IF, Baamonde C, Garcia-Calatayud S, Lumbreras MA, Florez J (1997) Alternations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome. Brain Res 749: 238-244
5. Frank DA, Greenberg ME (1994) CREB: a mediator of long-term memory from mollusks to mammals. Cell 79: 5-8
6. Frey U, Huang Y-Y, Kandel ER (1993) Effects of cAMP stimulate a late stage of LTP in hippocampal CA1 neurons. Science 260: 1661-1664
7. Girault J-A, Shalaby IA, Rosen NL, Greengard P (1988) Regulation by cAMP and vasoactive intestinal peptide of phosphorylation of specific proteins in striatal cells in culture. Proc Natl Acad Sci USA 85: 7790-7794
8. Girault J-A, Horiuchi A, Gustafson EL, Rosen NL, Greengard P (1990) Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specially associated with dopamine-innervated brain region. J Neurosci 10: 1124-1133
9. Greengard P (1987) Neuronal phosphoproteins. Mediators of signal transduction. Mol Neurobiol 1: 81-119
10. Horiuch A, Williams KR, Kurihara T, Nairn AC, Greengard P (1990) Purification and cDNA cloning of ARPP-16, a cAMP-regulated phosphoprotein enriched in basal ganglia, and of a related phosphoprotein, ARPP-19. J Biol Chem 265: 9476-9484
11. Linden DJ, Ahn S (1999) Activation of presynaptic cAMP-dependent protein kinase is required for induction of cerebellar long-term potentiation. J Neurosci 19: 10221-10227
12. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
13. Nairn AC, Hemmings HC Jr, Greengard P (1985) Protein kinases in the brain. Ann Rev Biochem 54: 931-976
14. Nestler EJ, Greengard P (1983) Protein phosphorylation in the brain. Nature 305: 583-588
15. Ohm TG, Bohl J, Lemmer B (1989) Reduced cAMP-signal transduction in postmortem hippocampus of demented old people. Prog Clin Biol Res 317: 501-509
16. Parks KM, Sugar JE, Haroutunian V, Bierer L, Perl D, Wallace WC (1991) Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues. Brain Res Mol Brain Res 9: 125-134
17. Perdahl E, Adolfsson R, Alafuzoff I, Albert KA, Nestler EJ, Greengard P, Winblad B (1984) Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia. J Neural Transm 60: 133-141
18. Ross BM, McLaughin M, Roberts M, Milligan G, McCulloch J, Knowler JT (1993) Alternations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Res 622: 35-42
19. Schnecko A, Witte K, Bohl J, Ohm T, Lemmer B (1994) Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected. Brain Res 644: 291-296
20. Siarey RJ, Carlson EJ, Epstein CJ, Balbo A, Rapoport SI, Galdzicki Z (1999) Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology 38: 1917-1920
21. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1998) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38: 359-364
22. Walaas SI, Greengard P (1991) Protein phosphorylation and neuronal function. Pharmacol Rev 43: 299-349
23. Yamamoto M, Ozawa H, Saito T, Frolich L, Riederer P, Takahata N (1996) Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type. Neuroreport 7: 2965-2970
24. Yamamoto M, Ozawa H, Saito T, Hatta S, Riederer P, Takahata N (1997) Ca2+/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: possible relation to type I adenylyl cyclase. J Neural Transm 104: 721-732
25. Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P (1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824: 300-303